Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination therapy of Western medicine and traditional Chinese medicine for chronic hepatitis C
ChiCTR-TRC-10000770Phase 4Completed
- Sponsor
- Shuguang Hospital
- Start
- Oct 2008
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Binggan Granule, interferon alfa and ribavirin in hepatitis C virus infection (4 arms), sponsored by Shuguang Hospital. Primary endpoints: HCV RNA, Liver biopsy and 4 more. Started Oct 2008; status: completed.
02
Drugs
Binggan Granuleinterferon alfaribavirin
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on ChiCTR-TRC-10000770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000770.